Invesco has just printed Q2 earnings and the Street has responded with a fresh round of target lifts — but the stock slipped 2.3% on the day, and shorts have quietly added to positions all week.
The analyst reaction to Tuesday's release was uniformly constructive on targets while leaving ratings intact. JP Morgan raised its target to $29.50 from $29.00, maintaining Neutral. RBC Capital moved to $35 from $33, holding Outperform. Barclays nudged to $32 from $31, staying Equal-Weight. That pattern — higher targets, unchanged ratings — mirrors exactly what the pre-earnings note flagged last Friday. The consensus mean target has now risen to $32.46, roughly 10% above the current $29.43 close. The Street sees more value than it did a month ago, but not enough to upgrade wholesale.
Short positioning tells a more cautious story post-earnings. Short interest climbed nearly 7% across the week to 4.4% of the free float — around 19.8 million shares — the highest reading in the past 30 days. That move came in two distinct steps: a jump through July 22-23 and then a further tick up yesterday. The borrow market remains extremely loose, which is the key counterpoint. Availability is at 3,794% — meaning there are roughly 38 shares available to borrow for every one already borrowed — and cost to borrow has fallen sharply to 0.35%, down 23% on the week and 39% over the past month. Shorts are rebuilding, but conditions in the lending pool create no friction at all for doing so. This looks more like tactical positioning than a structural conviction bet.
Options positioning has also drifted more defensive through the week, though the move remains measured. The put/call ratio closed at 0.236, about 1.3 standard deviations above its 20-day mean of 0.188 — elevated but well short of the 52-week high of 0.383. That reading was already stretched before earnings; it has held steady rather than spiking further on the print. Options traders appear to have retained their hedges rather than unwound them on the result, which is consistent with the broader "constructive but cautious" tone across positioning.
The earnings momentum factor ranks in the 90th percentile on a 30-day basis and the 81st on a 90-day basis — Invesco has been beating estimates consistently. Forward EPS estimates for the year are trending higher, ranking at the 70th percentile. The ORTEX short score edged up to 41.1 this week from around 39.5 a week ago, a modest but directionally notable move that reflects the fresh short interest building. Peers gave a mixed picture on the day: BLK rose 3.3% while GS fell 1.4% and MS shed 1.4%, suggesting Tuesday's financial-sector tape was mixed rather than uniformly negative for asset managers.
On the insider front, the most recent logged activity — a cluster of sells on July 2 at $27.01 — preceded the stock's current level by nearly three dollars. The CFO sold roughly $1.4 million and a senior managing director sold over $4.2 million at that level. With the stock now at $29.43, those sellers exited below where it trades today, though the sales were flagged as routine low-significance transactions. There has been no buying activity in the recent record.
The next earnings event is flagged for October 27. Between now and then, the focus narrows to whether the target lifts from JP Morgan, RBC, and Barclays translate into actual rating upgrades — the gap between $29.43 and a $35 RBC target is wide enough that continued momentum could eventually force the issue — and whether the short interest that rebuilt this week continues to accumulate or fades as post-earnings uncertainty resolves.
See the live data behind this article on ORTEX.
Open IVZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
